March 2015 FDA Recall Drug by Mylan Pharmaceuticals Inc.
D-0435-2015 - Failed Impurities/Degradation Specifications

This Class III drug recall was voluntarily initiated by Mylan Pharmaceuticals Inc. on March 11, 2015 for the product Drug. The FDA reported the reason for recall as failed impurities/degradation specifications. The product was distributed Nationwide and the recall is currently terminated.

Recall Number: D-0435-2015

Reason for Recall
Failed Impurities/Degradation Specifications: out of specification results for a related compound - a degradant of fexofenadine.
Initiated
03-11-2015
Reported
04-15-2015
Quantity
13,856 Bottles

Recall Profile & Regulatory Data

Class III - is a situation in which use of, or exposure to, a violative product is not likely to cause adverse health consequences.
Mylan Pharmaceuticals Inc.
Fexofenadine HCl Tablets, USP, 60 mg, Allergy, Antihistamine, Indoor and Outdoor Allergies, Non-Drowsy, Original Prescription Strength, a) 60 count Bottles, NDC 0378-0781-91, b) 500 count Bottles, NDC 0378-0781-05, Manufactured by: Mylan Pharmaceuticals Inc, Morgantown, WV, 26505, USA.

Batch or Lot Expiration Information

Lot# : 3047303, Exp 04/2015